Oragenics to showcase EvoraPro

TAMPA, Florida--Florida-based biopharmaceutical company Oragenics plans to exhibit the new professional-strength oral care probiotic, EvoraPro, at the American Dental Association’s Annual Session and World Marketplace Exhibition October 9-12, 2010, in Orlando, Fla.

“Exhibiting at the American Dental Association’s Annual Session is an excellent opportunity for us to introduce EvoraPro professional strength oral care probiotics to a wide range of dental professionals,” said Gerry David, executive vice president, sales and marketing for Oragenics.

ProBiora3, the active ingredient in Oragenics' probiotic products, naturally supports gum and tooth health while freshening breath and whitening teeth. ProBiora3 technology was developed by Oragenics' Chief Scientific Officer Dr. Jeffrey Hillman, DMD, PhD, during more than 25 years of research that began at the Harvard-affiliated Forsyth Institute in Boston and continued at the University of Florida.

This technology has only recently become available to the general public. ProBiora3 contains three strains of beneficial bacteria that help maintain a healthy microbial balance in the mouth. It is 100% natural and is made in the USA in an FDA-registered and GMP-certified facility.

For more information, go to www.oragenics.com.

To read more about Oragenics, go to Oragenics.

To comment on this subject, go to community.pennwelldentalgroup.com/.